Xavier Matias-Guiu Guia

Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomic S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X

Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.

VIRCHOWS ARCHIV 478 851-863. 01/05/2021.

[doi:10.1007/s00428-020-02962-x]

Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B

Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.

Modern Pathology 34 994-1007. 01/05/2021.

[doi:10.1038/s41379-020-00721-6]

Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Arozarena, I; Guerrero-Setas, D; Zudaire, T; Guarch, R; Vidal, A; Salas, JS; Matias-Guiu, X; Ausin, K; Gil, C; Hernandez-Alcoceba, R; Martin-Sanchez, E

Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix

Cancers 13 -. 01/04/2021.

[doi:10.3390/cancers13071739]

Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium

The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.

HUMAN PATHOLOGY 109 80-91. 01/03/2021.

[doi:10.1016/j.humpath.2020.12.003]

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

RADIOTHERAPY AND ONCOLOGY 154 327-353. 01/03/2021.

[doi:10.1016/j.radonc.2020.11.018]

Bosse, T; Lax, S; Abu-Rustum, N; Matias-Guiu, X

The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 40 102-110. 01/03/2021.

[doi:10.1097/PGP.0000000000000755]

Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

VIRCHOWS ARCHIV 478 153-190. 01/02/2021.

[doi:10.1007/s00428-020-03007-z]

Frias-Gomez J; Peremiquel-Trillas P; Alemany L; Ameijide A; Marcos-Gragera R; Ponce J; Brunet J; Matias-Guiu X; Galceran J; Izquierdo Á; Borràs JM; Costas L; Clèries R

Predicting the rising incidence and mortality of endometrial cancers among women aged 65-74 years in Catalonia.

MATURITAS 144 11-15. 01/02/2021.

[doi:10.1016/j.maturitas.2020.09.006]

Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 12-39. 01/01/2021.

[doi:10.1136/ijgc-2020-002230]

MATIAS-GUIU GUIA, XAVIER

Endometrial Cancer Histopathology Reporting Guide

Endometrial Cancer Histopathology Reporting Guide -. 01/01/2021.

Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A

An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.

GYNECOLOGIC ONCOLOGY 159 721-731. 01/12/2020.

[doi:10.1016/j.ygyno.2020.09.013]

Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

ANNALS OF ONCOLOGY 31 1606-1622. 01/12/2020.

[doi:10.1016/j.annonc.2020.08.2102]